Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LQDA Liquidia Technologies Inc

Not Yet Opened 12-22 16:00:00 EST

35.78

+1.25

+3.62%

盘后35.70

-0.08-0.22%

18:25 EST

High36.11	Low34.60	Vol953.98K
Open35.24	D1 Closing34.53	Amplitude4.37%
Mkt Cap3.11B	Tradable Cap2.15B	Total Shares87.00M
T/O34.04M	T/O Rate1.59%	Tradable Shares60.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LQDA","market":"US","secType":"STK","nameCN":"Liquidia Technologies Inc","latestPrice":35.78,"timestamp":1766437200000,"preClose":34.53,"halted":0,"volume":953984,"hourTrading":{"tag":"盘后","latestPrice":35.7,"preClose":35.78,"latestTime":"18:25 EST","volume":26711,"amount":955682.4295,"timestamp":1766445954954},"delay":0,"floatShares":60054376,"shares":86995483,"eps":-1.452333,"marketStatus":"Not Yet Opened","change":1.25,"latestTime":"12-22 16:00:00 EST","open":35.24,"high":36.11,"low":34.6001,"amount":34039564.832256,"amplitude":0.043727,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.452333,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766480400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1532577600000,"exchange":"NASDAQ","adjPreClose":34.53,"preHourTrading":{"tag":"盘前","latestPrice":35.5401,"preClose":34.53,"latestTime":"09:27 EST","volume":3961,"amount":140707.323902,"timestamp":1766413669316},"postHourTrading":{"tag":"盘后","latestPrice":35.7,"preClose":35.78,"latestTime":"18:25 EST","volume":26711,"amount":955682.4295,"timestamp":1766445954954},"volumeRatio":0.811022,"optionData":{"bulkOrders":[{"symbol":"LQDA","call":true,"expireDate":1768539600000,"strike":"40.0","timestamp":1766431746049,"price":1.7,"volume":1521,"amount":258570,"type":"+"},{"symbol":"LQDA","call":true,"expireDate":1768539600000,"strike":"30.0","timestamp":1766431746048,"price":7.07,"volume":1521,"amount":1075347,"type":"-"}]},"impliedVol":0.9606,"impliedVolPercentile":0.5},"requestUrl":"/m/hq/s/LQDA","defaultTab":"news","newsList":[{"id":"2591725256","title":"Is It Too Late To Consider Liquidia After Its 182.6% 2025 Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2591725256","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591725256?lang=en_us&edition=fundamental","pubTime":"2025-12-16 08:33","pubTimestamp":1765845238,"startTime":"0","endTime":"0","summary":"If you are wondering whether Liquidia is still a smart buy after its huge run, you are not alone. This is exactly the kind of stock where valuation really matters.\nThe share price has pulled back about 2.3% over the last week, but it is still up 21.9% over 30 days and 182.6% year to date, with a 210.0% gain over the past year and 992.3% over five years.\nThose moves have been driven by growing optimism around Liquidia's pipeline and regulatory progress, with investors reacting positively to...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/is-it-too-late-to-consider-liquidia-after-its-1826-2025-surg","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/is-it-too-late-to-consider-liquidia-after-its-1826-2025-surg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","LQDA","DCF"],"gpt_icon":0},{"id":"2586729034","title":"A Fresh Look at Liquidia (LQDA) Valuation After Strong Share Price Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2586729034","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586729034?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:34","pubTimestamp":1764081256,"startTime":"0","endTime":"0","summary":"Liquidia (LQDA) shares have been trending steadily higher over the past month, outpacing the broader biotech sector. The climb has caught the attention of investors who are looking for momentum plays in innovative healthcare names.\nSee our latest analysis for Liquidia.\nLiquidia’s impressive move this past month, with a 33.5% share price return, builds on robust momentum that has been gathering steam all year. In fact, the company’s year-to-date share price return has surged 146.9%, and those...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/a-fresh-look-at-liquidia-lqda-valuation-after-strong-share-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/a-fresh-look-at-liquidia-lqda-valuation-after-strong-share-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LQDA","DCF","BK4007"],"gpt_icon":0},{"id":"2584192587","title":"Liquidia LIQUIDIA Q3 EPS USD -0.04 VS. IBES ESTIMATE USD -0.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2584192587","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584192587?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:25","pubTimestamp":1763569532,"startTime":"0","endTime":"0","summary":"Nov 03 (Reuters) - Liquidia Q3 operating income USD 1.767 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 03-NOV-202511:30:46.023 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD8FCsYG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2583669046","title":"A Fresh Look at Liquidia (LQDA) Valuation Following Strong Q3 Revenue Growth and Narrowed Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2583669046","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583669046?lang=en_us&edition=fundamental","pubTime":"2025-11-16 15:21","pubTimestamp":1763277673,"startTime":"0","endTime":"0","summary":"Liquidia (LQDA) just released its third quarter results, revealing revenue that jumped significantly from last year and a net loss that narrowed sharply compared to the same period in 2024. These numbers are catching investor attention right now.\nSee our latest analysis for Liquidia.\nLiquidia has staged an impressive run this year, with strong financial results helping to power a remarkable 131.7% year-to-date share price return and a 1-year total shareholder return of 185%. Momentum remains...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/a-fresh-look-at-liquidia-lqda-valuation-following-strong-q3","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/a-fresh-look-at-liquidia-lqda-valuation-following-strong-q3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LQDA"],"gpt_icon":0},{"id":"2583684358","title":"Why Liquidia (LQDA) Is Up 5.2% After Posting Substantial Q3 Revenue Growth and Reduced Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2583684358","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583684358?lang=en_us&edition=fundamental","pubTime":"2025-11-15 03:23","pubTimestamp":1763148191,"startTime":"0","endTime":"0","summary":"Liquidia Corporation recently reported its third quarter 2025 earnings, revealing US$54.34 million in revenue and a net loss of US$3.53 million, compared to US$4.45 million in revenue and a net loss of US$31.03 million in the same quarter last year.\nThis sharp increase in revenue and narrowing of net loss highlights a period of significant operational progress for the company.\nWe’ll now explore how Liquidia’s substantial revenue growth shapes its broader investment narrative and prospects...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/why-liquidia-lqda-is-up-52-after-posting-substantial-q3-reve","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/why-liquidia-lqda-is-up-52-after-posting-substantial-q3-reve","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LQDA"],"gpt_icon":0},{"id":"2583583796","title":"Liquidia Chief Accounting Officer Dana Boyle Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583583796","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583583796?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:31","pubTimestamp":1762983067,"startTime":"0","endTime":"0","summary":"Dana Boyle, Chief Accounting Officer of Liquidia Corporation, reported a disposal of common shares of Liquidia Corporation. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liquidia Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL7cqnDd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Liquidia Chief Accounting Officer Dana Boyle Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2581831472","title":"Liquidia Chief Medical Officer Rajeev Saggar Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2581831472","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581831472?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:31","pubTimestamp":1762551087,"startTime":"0","endTime":"0","summary":"Rajeev Saggar, Chief Medical Officer of Liquidia Corporation, reported a disposal of common shares of Liquidia Corporation. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liquidia Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 07, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL67vDmd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Liquidia Chief Medical Officer Rajeev Saggar Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"1156959518","title":"Stock Track | Liquidia Technologies Soars 5.33% as Multiple Analysts Raise Price Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=1156959518","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156959518?lang=en_us&edition=fundamental","pubTime":"2025-11-04 23:19","pubTimestamp":1762269591,"startTime":"0","endTime":"0","summary":"Shares of Liquidia Technologies Inc (LQDA) are soaring 5.33% in early trading on Tuesday, following a series of positive analyst updates. The stock's surge comes as several prominent financial...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["LQDA"],"gpt_icon":0},{"id":"2580758383","title":"Liquidia Corp : H.c. Wainwright Raises Target Price to $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2580758383","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580758383?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:21","pubTimestamp":1762266103,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WG1PQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2580020736","title":"Liquidia Corp : Raymond James Raises Target Price to $47 From $41","url":"https://stock-news.laohu8.com/highlight/detail?id=2580020736","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580020736?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:30","pubTimestamp":1762259416,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WG0ZA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2580178471","title":"Liquidia Price Target Maintained With a $49.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2580178471","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580178471?lang=en_us&edition=fundamental","pubTime":"2025-11-04 18:43","pubTimestamp":1762252980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LQDA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 04, 2025 05:43 ET (10:43 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2580620828","title":"Liquidia Corp : Needham  Raises Target Price to $52 From $36","url":"https://stock-news.laohu8.com/highlight/detail?id=2580620828","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580620828?lang=en_us&edition=fundamental","pubTime":"2025-11-04 13:06","pubTimestamp":1762232785,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WF2AT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2580231802","title":"Liquidia price target raised to $45 from $43 at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2580231802","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580231802?lang=en_us&edition=fundamental","pubTime":"2025-11-04 05:00","pubTimestamp":1762203608,"startTime":"0","endTime":"0","summary":"Jefferies raised the firm’s price target on Liquidia (LQDA) to $45 from $43 and keeps a Buy rating on the shares following a strong Q3 that beat co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-price-target-raised-to-45-from-43-at-jefferies-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-price-target-raised-to-45-from-43-at-jefferies-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"1154806394","title":"Stock Track | Liquidia Plummets 5% Despite Strong Q3 Results, Suggesting Profit-Taking","url":"https://stock-news.laohu8.com/highlight/detail?id=1154806394","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154806394?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:39","pubTimestamp":1762180740,"startTime":"0","endTime":"0","summary":"Liquidia Corporation (NASDAQ: LQDA) shares plummeted 5.05% in Monday's pre-market trading, despite reporting better-than-expected third-quarter results. The biopharmaceutical company, focused on...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["LQDA"],"gpt_icon":0},{"id":"1101385977","title":"Stock Track | Liquidia Stock Plunges 5% Despite Strong Q3 Results, Puzzling Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=1101385977","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101385977?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:38","pubTimestamp":1762180732,"startTime":"0","endTime":"0","summary":"Shares of Liquidia Technologies Inc (LQDA) took an unexpected turn in pre-market trading on Monday, plummeting 5.05% despite the company reporting better-than-expected third-quarter results. This...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["LQDA"],"gpt_icon":0},{"id":"2580110862","title":"Liquidia Shares Reverse Premarket Course, Last Down 1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580110862","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580110862?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:36","pubTimestamp":1762180573,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL4N3WF10P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2580215167","title":"Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Monday Amid AI Demand, US-China Deal Hope","url":"https://stock-news.laohu8.com/highlight/detail?id=2580215167","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580215167?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:24","pubTimestamp":1762176299,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively traded Invesco QQQ Trust (QQQ) was 0.7% higher in Monday's premarket activity amid an expected US-China ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IYK","IYH","IGM","AMG","AMG.AU","FAS","XLI","SPY.AU","XLF","XRT","HOPE","IYW","XSD","CIVI","SPY","PMR","VDC","LQDA","VHT.AU","XLV","ACIW","BITO","RTH.AU","EETH","VHT","RTH","KMB","USO","XLK","VIS","XLP","IPK","SOXX","CMPO","FAZ","UNG","IYJ","BETH","IYE","SM","EEM","EQR","IBB","KVUE","XLE","XLY","IVV"],"gpt_icon":1},{"id":"2580213385","title":"Liquidia Corporation to Present at UBS Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2580213385","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580213385?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:00","pubTimestamp":1762174851,"startTime":"0","endTime":"0","summary":"Liquidia Corporation will provide business updates during a fireside chat at the 2025 UBS Global Healthcare Conference on November 10 in Palm Beach Gardens, Florida. The company's executive leadership team will present information about their progress in treating respiratory and vascular diseases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liquidia Corporation published the original content used to generate this news brief via GlobeNewswire  on November 03, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL5DsxqS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00B3QW5Z07.USD","BK4112","BK4585","LU0314104364.USD","LU2095319765.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LQDA","BK4588","LU2210149790.SGD","LU2210150020.SGD","NDAQ","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2580292340","title":"CORRECTED-Pulmonary drug developer Liquidia posts operating profit in first full quarter of YUTREPIA sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2580292340","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580292340?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:43","pubTimestamp":1762170186,"startTime":"0","endTime":"0","summary":"CORRECTED-Pulmonary drug developer Liquidia posts operating profit in first full quarter of YUTREPIA salesCorrects total revenue to $54.34 mln, from $51.7 mln, and removes comparison with estimates in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL1N3WF0BZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2580947982","title":"Earnings Flash (LQDA) Liquidia Posts Q3 Loss $0.04 a Share, vs. FactSet Est of $0.39 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2580947982","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580947982?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:39","pubTimestamp":1762169945,"startTime":"0","endTime":"0","summary":"Earnings Flash (LQDA) Liquidia Posts Q3 Loss $0.04 a Share, vs. FactSet Est of $0.39 Loss","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LQDA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.liquidia.com","stockEarnings":[{"period":"1week","weight":0.0465},{"period":"1month","weight":0.2291},{"period":"3month","weight":0.5938},{"period":"6month","weight":1.6309},{"period":"1year","weight":2.2234},{"period":"ytd","weight":2.0425}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0391},{"period":"3month","weight":0.0326},{"period":"6month","weight":0.128},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1685}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.06042},{"month":2,"riseRate":0.857143,"avgChangeRate":0.087227},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.044853},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.072031},{"month":5,"riseRate":0.857143,"avgChangeRate":0.14078},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.074968},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.00324},{"month":8,"riseRate":0.5,"avgChangeRate":0.048271},{"month":9,"riseRate":0.375,"avgChangeRate":0.049793},{"month":10,"riseRate":0.625,"avgChangeRate":0.025896},{"month":11,"riseRate":0.75,"avgChangeRate":0.074904},{"month":12,"riseRate":0.75,"avgChangeRate":0.155763}],"exchange":"NASDAQ","name":"Liquidia Technologies Inc","nameEN":"Liquidia Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Liquidia Technologies Inc(LQDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Liquidia Technologies Inc,LQDA,Liquidia Technologies Inc股票,Liquidia Technologies Inc股票老虎,Liquidia Technologies Inc股票老虎国际,Liquidia Technologies Inc行情,Liquidia Technologies Inc股票行情,Liquidia Technologies Inc股价,Liquidia Technologies Inc股市,Liquidia Technologies Inc股票价格,Liquidia Technologies Inc股票交易,Liquidia Technologies Inc股票购买,Liquidia Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Liquidia Technologies Inc(LQDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}